CPG

Guideline for the Use of PSA and the Early Diagnosis of Prostate Cancer

PUBLISHED: 1997	REVISED:December 2005
TOPIC: Cancer	SCOPE: Screening recommendations, monitoring of PSA
ABSTRACT: This guideline assists physicians and patients to make informed decisions about PSA testing as a screening tool and the appropriate use of PSA testing for follow-up in men who have had prostate cancer
TARGET POPULATION: • The appropriate use of PSA testing can include: follow-up of a man with prostate cancer; evaluation of a man with an abnormal DRE, evaluation of a man with lower urinary tract symptoms • PSA testing should be discussed with men at higher risk for the development of prostate cancer and men who express a concern about the development of prostate cancer
EXCLUSIONS: Men with a life expectancy of less than 10 years

Summary: Use of the PSA and Screening for Prostate Cancer

Guideline: Use of PSA and Screening for Prostate Cancer

Patient Information: Prostate Cancer

Working Group

A multidisciplinary team composed of:

Family Physicians
Urologists
Medical Oncologist
Medical Biochemist
Radiologist
Pathologist
RN
Public Representative
CME Educator